Evelyn Hogg Selected Research

RNA (Ribonucleic Acid)

1/2022	Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297).
1/2021	Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy.
10/2019	Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART.
1/2018	Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART.
4/2017	Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
5/2014	Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine.
7/2010	Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection.
1/2009	Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evelyn Hogg Research Topics

Disease

10	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 04/2008
7	Tuberculosis (Tuberculoses) 01/2020 - 10/2011
4	Viremia 01/2022 - 04/2017
4	Inflammation (Inflammations) 10/2019 - 04/2017
3	HIV Infections (HIV Infection) 01/2021 - 10/2007
3	Infections 01/2012 - 10/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2014 - 04/2008
1	Parasitemia 01/2022
1	Overweight 01/2021
1	Obesity 01/2021
1	Persistent Infection 10/2019
1	Body Weight (Weight, Body) 01/2015
1	Hypersensitivity (Allergy) 01/2015
1	Renal Insufficiency (Renal Failure) 05/2014
1	Mycoses (Diseases, Fungus) 07/2010
1	Immune Reconstitution Inflammatory Syndrome 07/2010
1	Opportunistic Infections (Opportunistic Infection) 01/2009
1	Hypertriglyceridemia 04/2008
1	Osteoporosis 11/2007
1	Cataract (Cataracts) 01/2006

Drug/Important Bio-Agent (IBA)

8	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2009
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2017
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 05/2014
3	Ritonavir (Norvir)FDA Link 01/2022 - 01/2012
3	Lopinavir FDA Link 01/2022 - 01/2012
3	Nevirapine (Viramune)FDA Link 10/2019 - 01/2012
3	Tenofovir (Viread)FDA Link 10/2019 - 05/2014
2	Fluspirilene (Imap)IBA 01/2022 - 01/2021
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020 - 03/2016
2	Emtricitabine (Emtriva)FDA Link 10/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 10/2019 - 10/2007
2	octaneIBA 10/2019 - 06/2014
2	CreatinineIBA 05/2014 - 01/2006
1	Reverse Transcriptase InhibitorsIBA 01/2022
1	Lipopolysaccharide ReceptorsIBA 10/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019
1	NeopterinIBA 10/2019
1	FumaratesIBA 01/2018
1	RacivirIBA 01/2018
1	Nucleic AcidsIBA 08/2017
1	AcidsIBA 08/2017
1	rifapentine (Priftin)FDA Link 01/2015
1	Dihydrotachysterol (AT 10)IBA 01/2015
1	RifamycinsIBA 01/2015
1	Rifampin (Rifampicin)FDA LinkGeneric 08/2013
1	efavirenz (Sustiva)FDA Link 08/2013
1	Fenofibrate (CiL)FDA LinkGeneric 04/2008
1	Fish OilsIBA 04/2008
1	Diphosphonates (Bisphosphonates)IBA 11/2007
1	amdoxovirIBA 10/2007
1	formal glycol (dioxolane)IBA 10/2007
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2007

Therapy/Procedure

13	Therapeutics 01/2022 - 04/2008
5	Art Therapy 10/2019 - 10/2007
1	Salvage Therapy 01/2020
1	Duration of Therapy 01/2015
1	Contraindications 01/2009